Ceramidase activity in porcine epidermis  by Wertz, Philip W. & Downing, Donald T.
Volume 268, number 1, 110-l 12 FEBS 08648 
Ceramidase activity in porcine epidermis 
July 1990 
Philip W. Wertz and Donald T. Downing 
Marshall Dermatology Research Laboratories, Department of Dermatology, University of Iowa College of Medecine, Iowa City, 
IA 52242, USA 
Received 19 May 1990; revised version received 30 May 1990 
This report presents the first demonstration of a ceramide-hydrolyzing activity in mammalian epidermis. An assay using fractions derived from 
porcine epidermis and synthetic PH]ceramide is described, and it is shown that under the conditions used, the K, for ceramide is 110 PM and 
hydrolysis is linear for up to 2 h. The enzyme activity is maximal at pH 8-9. The specific activity of ceramide hydrolase decreases as the protein 
concentration in the assay mixture increases, uggesting the possibility of a dissociable inhibitor. Also, the activity can be inhibited by added palmitic 
acid. Ceramide hydrolysis may be an important regulatory mechanism in the epidermis due to the ability of the liberated free sphingosine to modu- 
late the activity of protein kinase C. 
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1. INTRODUCTION 
The demonstration that sphingosine and related 
long-chain bases can inhibit protein kinase C [I] has led 
to much interest in this group of amines. Thus, it has 
been demonstrated that exogenously supplied sphingo- 
sines can inhibit a variety of protein kinase C-mediated 
events in cells in culture [l-4] and in vivo [5], and it has 
been proposed that endogenously produced sphin- 
gosine may serve as a second messenger 141. 
In mammalian epidermis, where ceramides are a 
major product of terminal differentiation, recent 
studies have revealed a much higher content of free 
long-chain bases [6] than found in other tissues [2,7,8]. 
It was proposed that this free sphingosine is produced 
by ceramide hydrolysis and may provide a feedback 
mechanism for the regulation of epidermal growth and 
differentiation [6]. If this is correct, then ceramide 
hydrolase should be demonstrable in epidermis. The 
present study demonstrates ceramide hydrolytic activity 
in fractions derived from pig epidermis. 
2. MATERIALS AND METHODS 
2.1. Preparation of epidermal homogenate 
Epidermis was prepared as previously described [9] and stored 
frozen at - 20°C. Epidermis (320 cm*), or an equal area of stratum 
corneum, was pulverized under liquid nitrogen with a mortar and 
pestle. The ground epidermis was allowed to warm to near room 
temperature before addition of 20 ml of 1 mM, pH 7.4, Tris-HCl 
containing 1 mM EDTA, 0.25 M sucrose and 12 mM sodium deoxy- 
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cholate. The mixture was ground an additional 3 min, sonicated for 
1 min, and centrifugation at 1000 x g for 10 min. The supernatant 
was used in the ceramidase assays. Protein was measured by a 
modification [lo] of the method of Lowry [ll]. 
2.2. Synthesis of ceramide 
[9, 10-3H]Palmitic acid (30-60 Ci/mmol; New England Nuclear, 
Boston, MA) was diluted with unlabeled palmitic acid (Sigma 
Chemical Co., St. Louis, MO) to a specific activity of 54 472 
dpm/nmol. Equimolar quantities of palmitic acid (17.9 mg), N-hy- 
droxysuccinimide (8 mg) and dicyclohexylcarbodiimide (14.4 mg) 
were dissolved in dry ethyl acetate (0.33 ml) and allowed to react 
overnight [12]. Ethyl acetate (3 ml) was added, and dicyclohexylurea 
was removed by filtration. In a modification of the method of Ong 
and Brady [13], the crude product was dried under nitrogen, dis- 
solved in freshly distilled ethyl ether and added to a 25% molar excess 
of sphingosine (Sigma Chemical Co.). After 18 h at room temper- 
ature, the solvent was evaporated under nitrogen, and the ceramide 
product was isolated by preparative silicic acid thin-layer chroma- 
tography with a mobile phase consisting of chloroform methanol 
acetic acid (190:9: 1). The ceramide band was detected by scanning at 
210 nm with a photodensitometer (model CS 930; Shimadzu Corp., 
Kyoto, Japan). The appropriate region of silica gel was scraped from 
the plate, and the ceramide was eluted with chloroform methanol 
(2: 1). The final product, with a specific activity of 54 472 dpm/nmol, 
was recovered in 70% overall yield. 
2.3. Assay of ceramidase 
Ceramidase was assayed at 37°C in 0.6 ml of 40 mM buffer con- 
taining 0.21 M sucrose, 0.8 mM EDTA, 4 mg/ml sodium deox- 
ycholate, 0.7 mg/ml Triton X-100, 0.62 mM 13H]ceramide and 
0.1-0.5 mg of protein. Buffers used included citric acid (pH 3). 
acetate (pH 4 and 5), phosphate (pH 6 and 7), Tris-HCl (pH 8) and 
borate CpH 9). Reaction was terminated by addition of 100 pg 
palmitic acid and 4 ml 10% citric and 5 ml hexane. After mixing and 
centrifugation, the hexane phase was transferred to a clean tube and 
the aqueous phase was reextracted with an additional 5 ml hexane. 
The combined hexane extracts were dried under nitrogen, and the 
residue was redissolved in 100~1 of chloroform methanol (2:l). A 4-/l 
aliquot was taken for scintillation counting. A 16-~1 was applied to 
a lane on a thin-layer plate, which was then developed with hexane 
ethyl ether acetic acid (70:30:1). The distribution of radioactivity on 
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Fig. 1. Purity of synthetic [‘Hlceramide. The upper and lower panels 
show the distributions of carbon and radioactivity revealed by thin- 
layer chromatography of the synthetic ceramide. 
the plate was determined using a linear analyzer (model LB 284; Ber- 
thold Analytical Instruments, Nashua, NH). 
3, RESULTS AND DISCUSSION 
Fig. 1 demonstrates the chromatographic and radio- 
chemical purity of the synthetic ceramide substrate, the 
mobility of which was nearly identical to one of the 
previously characterized epidermal ceramides [ 141. 
Fig. 2 shows the time-dependent release of fatty acid 
from this substrate by ceramidase action. Boiling 
destroyed this activity (not shown). 
The pH profile of ceramidase activity in epidermal 
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Fig. 2. Release of fatty acid from ceramide reveaied by distribution 
of radiolabel on TLC. 
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Fig. 3. pH profile of ceramidase activity. 
homogenates (Fig. 3) contains two pH optima in the 
ranges of 4-5 and 8-9. Although acid ceramidase is a 
widely distributed lysosomal enzyme [is], the alkaline 
ceramidase shows greater activity and persisted meas- 
ureably into the stratum corneum. Therefore, all subse- 
quent experiments were performed with epidermal 
homogenates at pH 9. 
It was determined that the time course of ceramide 
hydrolysis by alkaline ceramidase is linear for up to 2 
h (Fig. 4) and the K,,, for ceramide was estimated to be 
110 1M (Fig. 5). When the concentration of protein in 
the assay mixture was varied, the rate of product’for- 
mation per mg protein decreased as the concentration 
of protein increased (Fig. 6). This observation indicates 
an endogenous dissociable inhibitor. Free fatty acid 
would be a likely candidate for such an inhibitor since 
fatty acid has previously been shown to inhibit cerami- 
dase [ 171 and is abundant in epidermis [ 141. Consistent 
with this view is the observation that the added palmitic 
acid inhibits activity in a dose-dependent manner 
(Fig. 7). Also, the difference in ceramidase activities 
between homogenates of whole epidermis and stratum 
corneum could be accounted for by differences in free 
fatty acid content, since the free fatty acid content of 
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Fig. 4. Time course of ceramide hydrolysis. 
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Fig. 5. Km= 1lOpM. 
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the epidermal and stratum corneum homogenates was 
found to be 85 and 265 ,ug/ml, respectively. 
Ceramidases have previously been identified in a 
variety of tissues [ 15-171, but this is the first report of 
ceramidase in epidermis. Ceramides are present in trace 
amounts in most tissues where they are intermediates in 
the synthesis and degradation of cerebrosides, sphin- 
gomyelins and higher glycosphingolipids. In epidermis, 
however, ceramides themselves are the principal dif- 
ferentiation products, making up 4OYo of the lipid in 
stratum corneum [14], and are the major constituents 
of the epidermal barrier to water loss [14]. Because the 
ceramides are terminal differentiation products of epi- 
dermis, it would seem that ceramide hydrolysis to 
liberate free sphingosine could provide a feedback 
mechanism for regulating differentiation and ceramide 
synthesis. 
In a previous study, it was demonstrated that the 
stratum corneum contains a higher concentration of 
free sphingosines than the viable cells 161. The action of 
ceramidase to liberate free long-chain bases either 
within the stratum corneum or at the boundary between 
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Fig. 6. Specific activity of ceramidase as a function of protein con- 
centration. 
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Fig. 7. Inhibition of ceramidase by added palmitic acid. 
the living and cornified cells may provide a mechanism 
for communication between the terminally differen- 
tiated epidermal compartment and the differentiating 
and replicating compartments. 
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